Greg Barrett

Greg Barrett Email and Phone Number

COO, EVOQ Therapeutics @ EVOQ Therapeutics
1600 Huron Parkway, Bldg 420
Greg Barrett's Location
New York City Metropolitan Area, United States, United States
Greg Barrett's Contact Details

Greg Barrett work email

Greg Barrett personal email

n/a
About Greg Barrett

Innovative and results-driven Commercial Business Leader with demonstrated experience delivering exceptional performance in highly competitive environments. Skilled at building and growing customer focused companies that consistently exceed financial objectives. Adept at optimizing organizational design/structure, improving management processes, identifying talent and enabling high-performing teams. Accomplished at leading US and International businesses and corporate partnerships across multiple regions. Proven track record of consistently strengthening company performance while reducing operating costs and creating authentic cultures of purpose, accountability, teamwork and respect. Areas of Expertise include:Senior Executive Leadership Experience:• Commercial leadership of new & growing companies• Financials - Full P&L, Investor Relations, Capital Raising, Forecasting & Budget Management• Organizational - Structure and Design | Short & Long-Range Business Plans• Sales | Marketing | Managed Markets | Operations• Brand Strategy & Management | Launch & Life Cycle Management of billion dollar portfolios• Deep expertise leading multiple corporate partnerships• Optimization of organizational culture and management systems• Access Strategy | Pricing | Payer Negotiation & Contracting• Market Research & Analytics• Business Development - in-licensing / out-licensing• Public Relations & Media Relations - including Investor Relations• Clinical Development | Research & DevelopmentTherapeutic Expertise:• Oncology / Immuno-Oncology - Multiple Tumor Types & Therapies• Cardiovascular: ACS, AF, DVT, PE• Hypertension• Hyperlipidemia / Cholesterol Management• Diabetes: Multiple Therapy Types• Biologics: Interferons, Vaccines, MoAbs…• Pain Management• Rheumatology• Antibiotics & Vaccines• Drug Delivery Devices• Disease Monitoring Devices

Greg Barrett's Current Company Details
EVOQ Therapeutics

Evoq Therapeutics

View
COO, EVOQ Therapeutics
1600 Huron Parkway, Bldg 420
Employees:
9
Greg Barrett Work Experience Details
  • Evoq Therapeutics
    Coo
    Evoq Therapeutics 2018 - Present
    EVOQ (e-voke) Therapeutics is a private immunotherapy company developing potent autoimmune disease therapies and cancer vaccines - utilizing our breakthrough vaccine modality. www.evoqtherapeutics.com
  • Broad Reach Consulting Llc
    President | C-Suite Commercial Leadership | Biotech & Pharma Consulting For Growing Companies
    Broad Reach Consulting Llc 2016 - 2017
    C-Suite & Board level Leadership and Commercial Consulting for new and emerging biotechnology and pharmaceutical companies
  • Daiichi Sankyo, Inc.
    Vice President | Marketing & Managed Markets Access Strategy
    Daiichi Sankyo, Inc. 2012 - 2015
    Basking Ridge, Nj, Us
    Senior Leader accountable for the US Commercial business of Daiichi Sankyo Co. Ltd (Japan’s 2rd largest Pharmaceutical Company). Full P&L responsibility the US portfolio of 10+ brands with annual gross sales of >$2.8 billion. Final decision-maker and signatory on all access strategies and contracts with Payers (gross-to-net investments of $1 billion). Promotional budget of $300 million/year. Team of 10 direct reports and an organization of 103 home office and field-based employees responsible for creating and executing annual, and long-range business plans across multiple therapeutic areas. US Commercial representative on numerous Global Commercial Committees.
  • Daiichi Sankyo, Inc.
    President | Daiichi Sankyo U.S. Commercial Division
    Daiichi Sankyo, Inc. 2013 - 2014
    Basking Ridge, Nj, Us
    Chosen by the worldwide CEO of Daiichi Sankyo Co. Ltd. (Tokyo) to lead the US commercial organization through a challenging restructuring. Led a team of 10 VP/C-Suite functional heads and the US Commercial Division of 2,500 employees responsible for achieving US sales and profit goals. Results / Achievements:Exceeded all performance targets: Gross sales +7% (~$2.8 billion), total revenue +8%, gross profit +9% and total profit contribution margin +21% - while guiding the organization through a challenging transition.US Commercial Division representative on: Global Management Committee (GMC), Global Strategy Committee (GSC), Global New Product Committee (GNPC), West Development Committee (WDC), and the Joint Molecule Steering Committee (Co-Chair with President of Lilly US Commercial).
  • Daiichi Sankyo, Inc.
    Vice President | Marketing | Commercial Operations | Market Research & Planning
    Daiichi Sankyo, Inc. 2007 - 2012
    Basking Ridge, Nj, Us
    Senior Leader responsible for achieving corporate Sales and Profit targets by managing multiple departments: Brand Management, Market Research, Market Planning, and Sales & Marketing Operations (including the Advertising Review Committee). Led staff of 8 direct reports and grew staff from 87 to 110+ employees responsible for the creation and execution of the annual, and long-range business plans for all in-line brands and near-term pipeline products across multiple therapeutic classes.
  • Daiichi Sankyo, Inc.
    Executive Director | Marketing | Market Research | Marketing Operations
    Daiichi Sankyo, Inc. 2001 - 2007
    Basking Ridge, Nj, Us
    Led a team of 80+ professionals across multiple disciplines that doubled and then tripled sales and profit as we grew the organization in both size and capability. Following the dissolution of the Sankyo Parke-Davis joint venture (due to the acquisition of Parke-Davis by Pfizer) we embarked on an ambitious plan for aggressive growth through product acquisitions (e.g. Welchol, FY15 sales >$800 million) and the launch and expansion of the olmesartan franchise and other pipeline products
  • Daiichi Sankyo, Inc.
    Executive Director | Marketing & Market Research
    Daiichi Sankyo, Inc. 1997 - 2001
    Basking Ridge, Nj, Us
    Recruited as employee #17 as Director of Marketing (and a founding member of the US Management Team) to build the Marketing and Operations functions for the new start-up Sankyo Parke Davis (a JV between Sankyo Co. Ltd. and Warner Lambert). Promoted to Senior Director of Marketing & Market Research, Promoted to Executive Director.
  • Schering-Plough Corporation
    Us Senior Brand Manager | Intron A | Oncology Biotech Division
    Schering-Plough Corporation 1996 - 1997
    Managed US Marketing for the company’s second largest brand, Intron®A (alpha interferon 2b) hepatitis indication. Significantly expanded sales and market share of the world’s #1 α-interferon. Led the cross-functional team responsible for US sales and marketing strategies and tactics. Partnered with R&D on lifecycle management. Developed strategies and tactics for the Sales and Managed Markets teams to execute.
  • Schering-Plough Corporation
    Global Product Manager | Intron A | Oncology & Hepatitis C
    Schering-Plough Corporation 1995 - 1996
    Promoted to Global Marketing for all territories outside the US with extensive (>60%) ex-US travel. Global liaison with the Presidents and Commercial Heads of all major European subsidiaries and other Western markets. Managed global brand strategy and lifecycle for SP’s 2nd largest product.
  • Schering-Plough Corporation
    Manager | Global Business Strategy & Analytics | Global Oncology Biotech Commercial Team
    Schering-Plough Corporation 1994 - 1995
    Recruited as a member of the Global Business Team responsible for global strategy, analytics and business development based in SP’s world headquarters with extensive (>50%) ex-US travel. Analyzed strategic performance analytics for Schering-Plough’s worldwide Oncology / Biotech portfolio, making recommendations to improve results. Identified acquisition targets to supplement the product portfolio of various subsidiaries for the Oncology & Biotechnology business.
  • American Cyanamid - Lederle Laboratories
    Specialty Sales Representative | Vaccines | Cardiovascular
    American Cyanamid - Lederle Laboratories 1993 - 1994
    New York, New York, Us
    Rotated into one of the company’s “more challenging” sales territories to promote key products – while building a strong working knowledge of Field Sales and Marketing. Promoted the Lederle-Praxis Biologics products to office and hospital based physicians including vaccines, oral and injectable antibiotics and hypertension brands.
  • American Cyanamid - Lederle Laboratories
    Senior Market Research Analyst | Oncology | Cardiovascular | Rheumatology | Biologics
    American Cyanamid - Lederle Laboratories 1992 - 1993
    New York, New York, Us
    Selected for professional development role relocating to corporate headquarters responsible for primary and secondary market research and analytics for Lederle’s Oncology, Cardiovascular and Rheumatology franchises with a budget of >$2 million. Worked with the VPs of Marketing and Business Development on the identification of, and the negotiation with, potential co-promotion partners for Lederle franchises.
  • American Cyanamid - Lederle Laboratories
    Clinical Trials Manager | Oncology
    American Cyanamid - Lederle Laboratories 1990 - 1992
    New York, New York, Us
    Managed Phase II-IV Clinical Development programs for Lederle’s Oncology Therapeutics by partnering with Research & Development, Regulatory Affairs, Legal Affairs and in-line Brand Teams. Directed clinical trials, site activation, on-site training and auditing of clinical research programs for multiple oncology disease states. Extensive (>50%) US travel.
  • American Cyanamid - Lederle Laboratories
    Research Biochemist | Biologics Division
    American Cyanamid - Lederle Laboratories 1989 - 1990
    New York, New York, Us
    Supervised team of 4-5 lab technicians in the Biologics Quality Assurance Department accountable for the Lederle’s vaccine business: HibTITER® (Haemophilus influenzae type b), DTP® (diphtheria, tetanus, pertussis), DTaP® (diphtheria, tetanus, acellular pertussis), HibDTP® (H. influenza type b, diphtheria, tetanus, pertussis), OPV® (oral poliomyelitis).
  • Us Army Corps Of Engineers
    Research Analyst | Construction Engineering Research Lab (Cerl)
    Us Army Corps Of Engineers 1988 - 1989
    Washington, Dc, Us
    Joint appointment (non-military) with the US Army Corp of Engineers and the University of Illinois - responsible for assessing the environmental impact of activities on US Army Bases and related facilities around the country. Significant travel to U.S. military bases.

Greg Barrett Education Details

  • The University Of Illnois At Urbana-Champaign
    The University Of Illnois At Urbana-Champaign
    Ms | Master Of Science In Biochemistry
  • Bridgewater State University
    Bridgewater State University
    Minor In Business
  • University Of Illinois And Bridgewater State University
    University Of Illinois And Bridgewater State University

Frequently Asked Questions about Greg Barrett

What company does Greg Barrett work for?

Greg Barrett works for Evoq Therapeutics

What is Greg Barrett's role at the current company?

Greg Barrett's current role is COO, EVOQ Therapeutics.

What is Greg Barrett's email address?

Greg Barrett's email address is gb****@****ics.com

What schools did Greg Barrett attend?

Greg Barrett attended The University Of Illnois At Urbana-Champaign, Bridgewater State University, University Of Illinois And Bridgewater State University.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.